Ionis Pharmaceuticals, Inc. Payments for Hedge, Financing Activities
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for the quarter ending 2022-12-31 was $0.00.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for the quarter ending 2022-09-30 was $0.00.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for the quarter ending 2021-12-31 was $0.00.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for the quarter ending 2021-09-30 was $0.00.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for fiscal 2023 was $0.00.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for fiscal 2021 was $136.62M.
- Ionis Pharmaceuticals, Inc. payments for hedge, financing activities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments for Hedge, Financing Activities 3 month | Payments for Hedge, Financing Activities 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-21 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 10-K · filed 2024-02-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $136.62M 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2019-12-31 | $108.68M 10-K · filed 2022-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 | |
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |